Related Experiment Video
Updated: Sep 12, 2025

Optimized Protocols for Mycobacterium leprae Strain Management: Frozen Stock Preservation and Maintenance in Athymic Nude Mice
Published on: March 23, 2014
Roadmap towards zero leprosy, Pakistan
Anil Fastenau1, Ali Murtaza2, Abdul Salam2
1German Leprosy and Tuberculosis Relief Association, Raiffeisenstrasse 3, 97080Wuerzburg, Germany.
Pakistan
Area of Science:
- Public Health
- Infectious Disease Epidemiology
- Global Health Initiatives
Background:
- Leprosy elimination is defined by the World Health Organization as zero child cases for five consecutive years.
- Pakistan's leprosy program has achieved significant case reductions through effective management and active case-finding.
- New adult cases decreased by 75% and child cases by 83% between 2001 and 2023.
Purpose of the Study:
- To outline Pakistan's "zero leprosy roadmap" to eliminate new child cases by 2030.
- To detail strategies for improving active case-finding and post-exposure prophylaxis.
- To enhance health information systems and healthcare provider capacity for leprosy diagnosis and referral.
Main Methods:
- Development of a "zero leprosy roadmap" focusing on key elimination strategies.
- Implementation of improved active case-finding and post-exposure prophylaxis for high-risk contacts.
- Upgrading the health information management system to DHIS2 and training healthcare professionals.
Main Results:
- Significant reduction in adult and child leprosy cases in Pakistan between 2001 and 2023.
- Development of a comprehensive roadmap to achieve zero new child cases by 2030.
- Emphasis on integrated strategies including enhanced surveillance, prophylaxis, and capacity building.
Conclusions:
- Pakistan's "zero leprosy roadmap" provides scalable strategies for leprosy elimination in low-endemic settings.
- The roadmap's success relies on active case-finding, prophylaxis, improved health systems, and stakeholder involvement.
- Lessons learned in Pakistan can guide global efforts toward leprosy elimination.
More Related Videos
12:22A Parasite Rescue and Transformation Assay for Antileishmanial Screening Against Intracellular Leishmania donovani Amastigotes in THP1 Human Acute Monocytic Leukemia Cell Line
Published on: December 30, 2012
12:02An Efficient Method for the Synthesis of Peptoids with Mixed Lysine-type/Arginine-type Monomers and Evaluation of Their Anti-leishmanial Activity
Published on: November 2, 2016
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...